Back
Revolution Medicines Inc (RVMD)
BiotechnologyRVMD · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$209.47
−1.13%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$-5.95
ROE
-76.7%
Gross margin
0.0%
Debt/Equity
0.29x
Revenue growth
P/B ratio
Beta
Forward P/E
Revolution Medicines Inc — company intelligence
Earnings surprises
Q2 2026$-3.06 vs $-2.02 est-51.7%
Q1 2026$-2.29 vs $-1.88 est-22.1%
Q4 2025$-1.86 vs $-1.61 est-15.4%
Q3 2025$-1.61 vs $-1.45 est-11.2%
Analyst consensus · 28 analysts
26 Buy2 Hold0 Sell
Updated Aug 17, 2026
Insider activity · 90 days
14 buys26 sellsnet -118,743 shares
Patel SushilSell 300 · Jun 29, 2026
Patel SushilSell 100 · Jun 29, 2026
Patel Sushilother 2,955 · Jun 29, 2026
Recent SEC filings
4 — Insider transaction reportAug 25, 2026
4 — Insider transaction reportAug 25, 2026
10-Q — Quarterly reportAug 5, 2026
Latest news
Bernstein Maintains Market Perform on Revolution Medicines, Raises Price Target to $179 — Benzinga · 4d ago
Truist Securities Maintains Buy on Revolution Medicines, Raises Price Target to $231 — Benzinga · 2w ago
Here’s How Much You Would Have Made Owning Revolution Medicines Stock In The Last 5 Years — Benzinga · 2w ago
High Risk, High Reward: Inside The Revolution Medicines Bull Case — SeekingAlpha · 2w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.